PCH
Polar Capital Holdings’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Buy |
+910,455
| New | +$21.8M | 0.11% | 133 |
|
|
2023
Q4 | – | Sell |
-8,705
| Closed | -$267K | – | 298 |
|
|
2023
Q3 | $267K | Hold |
8,705
| – | – | ﹤0.01% | 271 |
|
|
2023
Q2 | $349K | Sell |
8,705
-3,890
| -31% | -$156K | ﹤0.01% | 271 |
|
|
2023
Q1 | $514K | Hold |
12,595
| – | – | ﹤0.01% | 280 |
|
|
2022
Q4 | $486K | Hold |
12,595
| – | – | ﹤0.01% | 292 |
|
|
2022
Q3 | $670 | Buy |
12,595
+4,000
| +47% | +$213 | ﹤0.01% | 320 |
|
|
2022
Q2 | $501 | Buy |
8,595
+5,250
| +157% | +$306 | ﹤0.01% | 342 |
|
|
2022
Q1 | $255 | Sell |
3,345
-14,023
| -81% | -$1.07K | ﹤0.01% | 409 |
|
|
2021
Q4 | $1.05K | Hold |
17,368
| – | – | ﹤0.01% | 331 |
|
|
2021
Q3 | $973 | Hold |
17,368
| – | – | ﹤0.01% | 316 |
|
|
2021
Q2 | $1.05K | Buy |
+17,368
| New | +$1.05K | ﹤0.01% | 319 |
|